| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $226.5M | -32.9% |
| Cost of Revenue | $89.7M | -30.3% |
| Gross Profit | $136.8M | -34.5% |
| R&D Expense | $215.1M | +4.9% |
| SG&A Expense | $76.3M | -2.5% |
| Operating Income | -$154.6M | -108.1% |
| Pre-tax Income | -$148.5M | -109.4% |
| Income Tax | $20.9M | +476.2% |
| Net Income | -$169.4M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.9M | +27.6% |
| Accounts Receivable | $24.9M | -52.0% |
| Inventory | $29.0M | -28.3% |
| Current Assets | $280.2M | -8.0% |
| Total Assets | $657.7M | -7.4% |
| Current Liabilities | $83.0M | -0.6% |
| Total Liabilities | $97.8M | -6.1% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.0M | -56.9% |
| Investing Cash Flow | $7.8M | +107.3% |
| Financing Cash Flow | $4.5M | -20.9% |
| -159.1% |
| EPS (Basic) | -$4.25 | -150.0% |
| EPS (Diluted) | -$4.25 | -150.0% |
| Stockholders' Equity |
| $559.9M |
| -7.6% |